Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV sodium valproate versus IV dexamethasone for severe migraine headache
IRCT20180223038830N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of valproic acid and dexamethasone in migraine, migraine with aura and migraine without aura (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Decrease of migraine headache severity and related symptoms. Started Mar 2019; status: completed.
02
Drugs
valproic aciddexamethasone
03
Conditions
migrainemigraine with auramigraine without aura
Beyond the preview
Go deeper on IRCT20180223038830N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180223038830N1.